ChartRow logo
SUPN
$41.23+3.49%
as of close, Oct 20, 2026
☾ AH $41.23 +3.49%
PeersMRNALLYMDTUNHJNJTMO
Share this page

SUPN financial statements

The full income statement, balance sheet, and cash-flow statement for Supernus Pharmaceuticals Inc. (SUPN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 55.1M2024-09 55.2M2024-12 55.8M2025-03 56.0M2025-06 56.1M2025-09 57.3M2025-12 57.6M2026-03 58.0M2026-06 58.1M+5.5% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue719M+8.6%662M+8.9%608M-8.9%667M+15.1%580M+11.4%
Cost of revenue74.6M-4.3%77.9M-7.0%83.8M-3.9%87.2M—
Research & development106M-2.4%109M+18.8%91.6M+22.9%74.6M-17.6%90.5M+19.1%
Selling, general & administrative486M+51.0%322M-4.4%336M-10.8%377M+23.8%305M+51.9%
Amortization of intangibles89.5M+14.7%78.0M-5.4%82.4M-0.3%82.6M+175.5%30.0M+91.0%
Operating income-62.3M-176.3%81.7M+1649.9%-5.27M-111.4%46.1M-46.4%86.0M-50.5%
Interest expense0.000.00-100.0%2.42M-65.8%7.07M-64.1%19.7M+1.3%
Other non-operating income13.3M-18.2%16.2M+55.0%10.5M-51.8%21.7M+268.7%-12.9M-154.5%
Pre-tax income-49.0M-150.1%97.9M+3434.5%2.77M-95.4%60.7M-17.0%73.2M-56.6%
Income tax-10.5M-143.7%24.0M+1552.1%1.45M+4440.6%32.0K-99.8%19.8M-52.6%
-38.5M-152.2%73.9M+5512.8%1.32M-97.8%60.7M+13.6%53.4M-57.9%
Net income to common-38.5M-152.2%73.9M+5512.8%1.32M-98.0%64.3M+20.3%53.4M-57.9%
-$0.68-151.5%$1.32+6500.0%$0.02-98.1%$1.04+6.1%$0.98-58.5%
EPS (basic)-$0.68-150.7%$1.34+6600.0%$0.02-98.2%$1.13+11.9%$1.01-58.1%
Weighted-avg shares (basic)56.5M+2.5%55.1M+1.0%54.5M+1.6%53.7M+1.1%53.1M+0.9%
Weighted-avg shares (diluted)56.5M+0.9%56.0M+0.8%55.5M-10.0%61.7M+13.5%54.4M+1.2%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
644M-6.1%686M+39.1%493M-32.8%734M+22.0%602M-4.6%
Cash & equivalents128M+85.3%69.3M-7.6%75.1M-19.4%93.1M-54.2%203M-29.5%
Short-term investments——180M-51.2%368M+170.3%136M+1.8%
Accounts receivable188M+32.2%142M-1.4%144M-12.9%165M+11.1%149M+5.7%
Inventory112M+107.2%54.3M-29.9%77.4M-15.4%91.5M+6.5%86.0M+77.9%
Prepaid expenses65.3M+81.0%36.1M+116.4%16.7M+5.7%15.8M-41.6%27.0M+44.6%
1.45B+6.2%1.37B+7.1%1.28B-25.0%1.70B+0.8%1.69B+12.3%
Property, plant & equipment10.5M-8.8%11.5M-14.7%13.5M-10.8%15.2M-10.5%17.0M-55.2%
Operating lease right-of-use26.7M+9.1%24.5M-15.6%29.0M+0.3%28.9M-18.3%35.4M+74.8%
Goodwill125M+6.7%117M+0.0%117M+0.0%117M-0.4%118M+50.8%
Intangible assets569M+9.1%522M-13.0%600M-14.6%702M-10.5%785M+115.4%
Long-term investments——16.6M-82.3%93.9M-21.2%119M-66.0%
Deferred tax assets38.4M0.00———
Other non-current assets63.8M+102.4%31.5M-15.9%37.5M-5.8%39.8M-19.1%49.2M+13.8%
338M+15.7%292M+0.8%290M-57.8%688M+118.1%315M+28.7%
Accounts payable2.68M-41.6%4.59M+133.6%1.96M-81.4%10.5M+13.0%9.33M+51.8%
Accrued liabilities108M+41.2%76.4M-4.0%79.6M-17.4%96.3M-18.1%118M+49.1%
Short-term & current debt
————0.00
Current lease liability10.6M+54.0%6.89M-17.3%8.33M+22.7%6.79M+4.8%6.48M+72.3%
Other current liabilities38.2M0.00-100.0%4.28M-74.6%16.9M-16.2%20.1M+121.7%
Finance lease liability (current)
————0.00-100.0%
391M+17.6%332M-6.7%356M-56.4%816M-6.5%873M+15.0%
Long-term debt
————379M
Non-current lease liability30.4M+10.9%27.4M-17.5%33.2M-7.8%36.0M-12.8%41.3M+44.5%
Operating lease liability (total)41.0M+19.6%34.3M-17.5%41.5M-2.9%42.8M-10.4%47.8M+47.7%
Finance lease liability
————0.00-100.0%
Deferred tax liabilities0.00-100.0%4.96M-80.1%25.0M-49.9%49.8M-41.6%85.4M+142.4%
Other non-current liabilities22.2M+192.0%7.60M+18.3%6.42M-26.1%8.69M-46.9%16.4M-61.7%
1.06B+2.5%1.04B+12.4%922M+4.0%886M+8.6%816M+9.5%
Common stock57.0K+1.8%56.0K+1.8%55.0K+1.9%54.0K+1.9%53.0K+0.0%
Additional paid-in capital544M+13.4%479M+9.1%439M+7.7%408M-6.0%434M+6.1%
Retained earnings518M-6.9%556M+15.3%483M+0.3%481M+26.7%380M+16.4%
Accumulated other comprehensive income-44.0K+76.7%-189K+68.1%-593K+81.5%-3.21M-308.6%1.54M-82.9%
Total liabilities & equity1.45B+6.2%1.37B+7.1%1.28B-25.0%1.70B+0.8%1.69B+12.3%
Common shares issued57.5M+3.1%55.7M+1.9%54.7M+0.9%54.3M+0.0%54.3M+1.9%
Common shares outstanding57.5M+3.1%55.7M+1.9%54.7M+0.9%54.3M+1.9%53.3M+0.7%
Shares outstanding (cover)57.6M+3.2%55.8M—54.4M+1.9%53.4M+0.9%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
47.3M-72.5%172M+54.8%111M-4.9%117M-8.1%127M-8.1%
Depreciation & amortization91.6M+13.9%80.4M-5.2%84.9M-0.8%85.5M+162.4%32.6M+79.7%
Intangible amortization89.5M+14.7%78.0M-5.4%82.4M-0.3%82.6M+175.5%30.0M+91.0%
Share-based compensation33.1M+19.1%27.8M+3.7%26.8M+52.3%17.6M-1.9%17.9M+8.1%
Deferred income taxes5.21M+125.9%-20.1M+21.7%-25.7M+2.3%-26.3M-427.1%-4.99M-979.2%
Change in receivables22.3M+1173.3%-2.08M+88.9%-18.8M-214.7%16.4M+523.2%-3.87M-111.2%
Change in inventory7.50M+147.5%-15.8M-158.7%-6.11M-134.2%17.9M+22.5%14.6M+44.0%
4.11M+102.2%-190M-170.7%269M+224.0%-217M-164.5%-81.9M-136.1%
Capital expenditure1.34M+84.6%725K+31.6%551K+33.7%412K—
Free cash flow46.0M-73.1%171M+54.9%111M-5.1%116M—
Acquisitions293M0.000.000.00-100.0%950K-99.7%
Sales/maturities of investments774M+55.2%499M+34.5%371M+94.5%191M—
9.13M-25.1%12.2M+103.1%-398M-3697.7%-10.5M+92.0%-130M-3764.5%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued37.6M+152.3%14.9M+125.5%6.61M-46.8%12.4M+75.1%7.09M+62.7%
Common stock repurchased0.000.000.000.000.00
Dividends paid0.000.000.000.000.00
Net change in cash60.6M+1158.3%-5.72M+68.3%-18.1M+83.6%-110M-29.5%-85.2M-179.4%
Interest paid0.000.00-100.0%1.95M-22.7%2.52M+0.0%2.52M+0.0%
Income taxes paid16.1M-69.9%53.3M+45.5%36.6M+125.9%16.2M-35.7%25.2M-44.5%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap2.86B+41.8%2.02B+27.7%1.58B-18.0%1.93B+23.9%1.56B+16.9%
P/E—27.3×-55.7%61.7×+20.6%51.2×+75.7%29.1×+177.8%
P/S4.0×+30.5%3.0×+17.8%2.6×-11.5%2.9×+9.0%2.7×+4.9%
P/B2.7×+38.3%1.9×+12.4%1.7×-23.3%2.3×+18.5%1.9×+6.7%
P/FCF62.2×+427.9%11.8×-30.6%17.0×+4.0%16.3×+23.9%13.2×+33.6%
Earnings yield—3.7%+125.8%1.6%-17.1%2.0%-43.1%3.4%-64.0%
FCF yield1.6%-81.1%8.5%+44.1%5.9%-3.9%6.1%-19.3%7.6%-25.1%
Source filing10-K10-K10-K10-K10-K

About this data

Source: SUPN’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all SUPN filings on SEC EDGAR → Not investment advice.